GSK plays defense on call to pull popular children`s asthma med
Mikal Watts, who is representing 89-year-old Angela Valadez, said the companies knew that Zantac’s active ingredient, ranitidine, would turn into a cancer-causing substance called NDMA as it aged or was exposed to extreme temperatures, but did not ensure it was properly handled by transporters, distributors and stores.
GSK raises forecasts on strong vaccine, HIV drug sales
Sen. Maggie Hassan (D-NH) is pressuring GSK to put a commonly used pediatric inhaler back on the market after the company stopped producing it in late 2023 in favor of an authorized generic version.
GSK (GSK) shares edged up 1.76% as the company reported a robust start to 2024, with first-quarter earnings revealing a mixed performance against analyst expectations but an improved profit outlook for the year. The pharmaceutical giant posted an adjusted EPS of GBP0.43, which fell short of the consensus estimate of GBP0.91. However, revenue reached GBP7.4 billion, a 10% increase compared to the same quarter last year but below the anticipated GBP8.85 billion.
May 1 (Reuters) - GSK (GSK.L), opens new tab raised its full-year profit forecast on Wednesday on strong demand for vaccines and specialty medicines though noted sales growth would slow in the second half.
GSK raised its full-year profit forecast on Wednesday on strong demand for vaccines and specialty medicines though noted sales growth would slow
Light trading volumes are expected in Europe on Wednesday, with only London's FTSE index open, due to the May Day/Labor Day public holiday in the region.
First trial over Zantac cancer claims set to begin in Chicago
FTC challenges ‘junk’ patents held by 10 drugmakers, including for Novo Nordisk’s Ozempic